中度无症状性颈动脉狭窄中药物治疗的真实世界应用
该研究回顾2019至2020年连续颈动脉双功超声检查,纳入255例中度(50%-69%)无症状性颈动脉狭窄患者,评估其达到最优药物治疗(OMT)的情况。首次检查时56.1%患者已达OMT,随访结束时升至68.6%;基线未达OMT者中仅38.4%在随访中达标,既往吸烟与未达标独立相关(HR 0.452,P=0.017)。
要点
- 首次双功超声时56.1%患者已达OMT,随访结束时升至68.6%。
- 基线未达OMT者中仅38.4%在随访中达标,中位随访2.7年。
- 既往吸烟与未达到OMT独立相关(HR 0.452,P=0.017)。
核心结论
- 在既往未接受OMT的中度ACS患者中,OMT达标率低;戒烟是提高OMT有效性的重要靶点。
研究设计与样本
- 回顾2019至2020年连续颈动脉双功超声检查,纳入基于血管外科学会指南的中度(50%-69%)ACS患者255例,共323次检查。
主要发现
- 255例患者中,首次双功超声时143例(56.1%)已达OMT,首次随访时升至163例(63.9%),研究结束时升至175例(68.6%)。
- 首次双功超声时112例(43.9%)未达OMT,其中43例(38.4%)在中位随访2.7年内达到OMT。
- 随访结束时,86例(76.8%)服用阿司匹林或其他抗血小板药,93例(83.0%)接受他汀或其他降脂治疗,74例(66.1%)戒烟。
- 既往吸烟与未达到OMT独立相关(HR 0.452,P=0.017)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite level 1 evidence demonstrating the benefit of carotid endarterectomy for the prevention of stroke in patients with severe asymptomatic carotid stenosis (ACS), there has been a trend toward recommending optimal medical therapy (OMT) alone. This recommendation has been promulgated based on the observation that modern advances in OMT reduce the overall stroke risk in the general population, but the success of this treatment strategy is dependent on patient and provider adherence. In current practice, patients with moderate ACS are nearly all treated with OMT alone. The objective of this study was to evaluate adherence to OMT in a cohort of patients with moderate ACS undergoing treatment with OMT alone. METHODS: Consecutive carotid duplex ultrasound examinations were reviewed for the years 2019 and 2020. Those with moderate (50%-69%) ACS based on Society for Vascular Surgery guidelines were included in the study. Patients were assessed for OMT at the time of the index duplex, the first follow-up visit, and at each subsequent follow-up visit until the end of the study. OMT was defined as abstinence from smoking, aspirin or other antiplatelet use, and statin or other lipid-lowering therapy. Patients were stratified based on their ability to achieve OMT, and each component was evaluated to identify shortfalls in therapy. RESULTS: A total of 323 duplex ultrasound examinations with moderate ACS in 255 patients were identified. Of the 255 patients, 143 (56.1%) were on OMT at the time of the first duplex; that number increased to 163 (63.9%) by the first follow-up visit and 175 (68.6%) by the completion of the study. There were 112 (43.9%) patients who were not on OMT at the time of the index duplex, 43 (38.4%) of whom achieved OMT over a median follow-up time of 2.7 years. By the end of follow-up, 86 (76.8%) were taking aspirin or another antiplatelet medication, 93 (83.0%) were on statin or other lipid-lowering therapy, and 74 (66.1%) were abstinent from smoking. Pre-duplex smoking was independently associated with failure to achieve OMT (hazard ratio: 0.452, P = .017). CONCLUSIONS: Among patients with moderate ACS who were not previously on OMT, the rate of OMT achievement is poor. Although advances in lipid management through statin therapy have been praised for their role in improving the effectiveness of OMT, smoking cessation represents an important target for improving uptake and as a result effectiveness of OMT.
引用
- Bloch RA, Ellias SD, Caron E, et al. Real-world use of medical therapy in moderate asymptomatic carotid stenosis. J Vasc Surg. 2024. PMID: 38906434. doi:10.1016/j.jvs.2024.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。